novo nordisk WORKS™ logo novo nordisk WORKS™ logo

For Employers

For Health Systems

For Payers

For FDMs

Novo Nordisk Works™ Formulary Decision Maker (FDM) Resources

Healthcare economic information resources from Novo Nordisk's health economics and outcomes research (HEOR) team. For Formulary Decision Makers only.

Download
Download

Obesity in a Claims-Based Analysis of the Commercially Insured Population

Milliman White Paper that discusses the impact of weight-loss therapy and anti-obesity medication (AOM) utilization on medical costs.
Download
Download

Milliman Analysis Overview

An in-depth look at the Milliman White Paper: Obesity in a Claims-Based Analysis of the Commercially Insured Population.
Download
Download

Cleveland Clinic Study Overview

An overview of the Cleveland Clinic case study and results, a study conducted by Novo Nordisk Inc.'s Health Economics and Outcomes Research (HEOR) team.

Sign up to receive the latest
developments in weight-management strategies

Sign up

Contact us to learn more

Find an Account Manager

Novo Nordisk WORKS™ is a trademark of Novo Nordisk A/S.

Novo Nordisk is a registered trademark of Novo Nordisk A/S.

© 2024 Novo Nordisk All rights reserved. US23OB00459 August 2024

OK

Now Exiting

You are about to leave the website of Novo Nordisk Works.

OK

Are You a Formulary Decision Maker?

The information on the following page is intended for Formulary Decision Makers only. Formulary Decision Makers are public and private sector payers, formulary committee members, or people in similar positions with expertise in healthcare economic analysis and who are involved in deciding drug coverage or reimbursement eligibility.

Access Resources

Sorry, you are not authorized to access this content

The role you selected is not considered a formulary decision maker.